홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

디클로페낙 나트륨

Diclofenac sodium

HCID 5018304
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
15307-79-6
표준 SMILES
O=C([O-])Cc1ccccc1Nc1c(Cl)cccc1Cl.[Na+]
InChIKey
KPHWPUGNDIVLNH-UHFFFAOYSA-M
분자식
C14H10Cl2NNaO2
평균 분자량
318.1 g/mol
단동위원소 질량
316.9986282

개요

Diclofenac sodium is the sodium salt of diclofenac. It contains a diclofenac(1-).

이름 및 식별자

우선 이름
Diclofenac sodium
IUPAC
sodium 2-[2-(2,6-dichloroanilino)phenyl]acetate
현지명
디클로페낙 나트륨
영어명
Diclofenac sodium
분자식
C14H10Cl2NNaO2
분자량
318.13

이름 및 동의어

Diclofenac sodium15307-79-6Diclofenac sodium saltSodium diclofenacSolarazeNeriodinProphenatinVoltarenDiclophenac sodiumAbitrenBenfofenDyloject
이름 더 보기
디클로페낙나트륨디클로페낙나트륨(DICLOFENACSODIUM)tsudohminDiclofenac SodiuAceclofenac EP IMpurity ASODIUM 2-(2,6-DICHLOROANILINO)PHENYLACETATEsodium 2-[2-(2,6-dichloroanilino)phenyl]acetateN-(2,6-Dichlorophenyl)-o-aminophenylacetic acid sodium saltNaclof
EcofenacPennsaidVoltareneVoltaren-XRGP 45840DiclophlogontDealgicDeflamat

데이터베이스 식별자

CAS
15307-79-6
PubChem CID
5018304
DTXSID
DTXSID3037208
ChEMBL
CHEMBL1034
ChEBI
CHEBI:4509
UNII
QTG126297Q
EC Number
239-346-4
Nikkaji
J8.556A

물성

구조 계산 물성

극성 표면적
52.2 Ų
수소 결합 공여자 수
1
수소 결합 수용자 수
3
회전 가능 결합 수
4
무거운 원자 수
20
형식 전하
0
복잡도
310

실험 및 물리화학적 성질

Human Drugs · 3건

Breast Feeding; Lactation; Milk, Human; Analgesic Agents; Anti-inflammatory Agents, Nonsteroidal

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Animal DrugsActive Ingredients (Diclofenac sodium) -> FDA Greenbook
Collision Cross Section157.2 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

물리화학적 성질

녹는점
288 · 288-290°C
밀도
0.781 g/cm3 · 0.781 g/cm3
저장 조건
room temp
용해도
2 O: · H2O: 50 mg/mL
산도 계수 (pKa)
4 · 4(at 25℃)
물리적 상태
흰색 고체
색상
흰색에서 거의 흰색
생물학적 소스
synthetic
수용성
50 mg/ml까지 · 50mg/ml까지 물에 용해됩니다.
Merck
14 · 14,3081
BCS Class
2 · 2
안정성
안정적인.
주요 응용
법의학 및 독성학의약품(소분자)
InChI
InChI=1S/C14H11Cl2NO2.Na/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19;/h1-7,17H,8H2,(H,18,19);/q;+1/p-1
InChIKey
KPHWPUGNDIVLNH-UHFFFAOYSA-M
SMILES
C1(=CC=CC=C1CC([O-])=O)NC1=C(Cl)C=CC=C1Cl.[Na+]

화학적 성질

Off-White Crystalline Solid

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 4건

Danger

H301 (96.7%): Toxic if swallowed [Danger Acute toxicity, oral]

P203, P260, P261, P264, P264+P265, P270, P271, P273, P280, P301+P316, P302+P352, P304+P340, P305+P351+P338, P316, P318, P319, P321, P330, P332+P317, P337+P317, P362+P364, P391, P403+P233, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 243 reports by companies from 43 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Regulatory Information · 2건

Status: Active Update: 27-05-2019 https://echa.europa.eu/registration-dossier/-/registered-dossier/13423

Diclofenac sodium: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - Benzeneacetic acid, 2-[(2,6-dichlorophenyl)amino]-, monosodium salt: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 3 (96.7%)

독성 정보

Exposure RoutesCompletely absorbed from the gastrointestinal tract.
Toxicity Summary · 1건

The antiinflammatory effects of diclofenac are believed to be due to inhibition of both leukocyte migration and the enzyme cylooxygenase (COX-1 and COX-2), leading to the peripheral inhibition of prostaglandin synthesis. As prostaglandins sensitize pain receptors, inhibition of their synthesis is responsible for the analgesic effects of diclofenac. Antipyretic effects may be due to action on the hypothalamus, resulting in peripheral dilation, increased cutaneous blood flow, and subsequent heat dissipation.

Signs and SymptomsSymptoms of overdose include loss of consciousness, increased intracranial pressure, and aspiration pneumonitis.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6건

Drug Induced Liver Injury Rank (DILIrank 2.0)

Diclofenac sodium

vMost-DILI-concern

8

Warnings & precautions

DOI:10.1016/j.drudis.2016.02.015

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation
Toxicity DataLD<sub>50</sub>=390mg/kg (orally in mice)

안전 데이터

wgk
3
rtecs
AG6330000
ridadr
UN 2811 6.1/PG 3
독성
LD50 in mice, rats (mg/kg): ~390, 150 orally (Krupp)
HS 번호
29224999
risk_code
25-36/37/38-63
hazard_code
T,Xi
safety_code
22-36/37-45-36-26-60-20
포장분류
III
위험 등급
6.1(b)
기존화학 물질
KE-10179
Hazard Classifications
Acute Tox. 3 OralAquatic Chronic 2Repr. 2STOT RE 1
스토리지 클래스
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects

화학 및 산업

약리 정보

Metabolism/Metabolites · 1건

Hepatic. Route of Elimination: Diclofenac is eliminated through metabolism and subsequent urinary and biliary excretion of the glucuronide and the sulfate conjugates of the metabolites. Little or no free unchanged diclofenac is excreted in the urine. Approximately 65% of the dose is excreted in the urine and approximately 35% in the bile as conjugates of unchanged diclofenac plus metabolites. Half Life: 2 hours

FDA Pharmacological Classification · 6건

DICLOFENAC SODIUM

Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]; Anti-Inflammatory Agents, Non-Steroidal [CS]; Decreased Prostaglandin Production [PE]

DICLOFENAC SODIUM 1%

Cyclooxygenase Inhibitors [MoA]; Anti-Inflammatory Agents, Non-Steroidal [CS]; Decreased Prostaglandin Production [PE]; Nonsteroidal Anti-inflammatory Drug [EPC]

DICLOFENAC SODIUM D/R

Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]; Decreased Prostaglandin Production [PE]; Anti-Inflammatory Agents, Non-Steroidal [CS]

MeSH Pharmacological Classification · 2건

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes.

용도 및 제조

UsesFor the acute and chronic treatment of signs and symptoms of osteoarthritis and rheumatoid arthritis.
Use ClassificationAnimal Drugs -> FDA Approved Animal Drug Products (Green Book) -> Active Ingredients
응용 분야 · 5건

용도1. 백내장 수술시 다음 증상의 방지. ·수술 후 염증 ·수술 중 축동. ·수정체 축출과 인공수정체 삽입술과 관련된 낭포황반부종. 2. 전안부의 염증 치료. ·만성 결막염등 비감염성 염증 ·외상 후 염증.

개요Diclofenac is a non-steroidal anti-inflammatory drug (NSAID) and COX inhibitor (IC50s = 0.9-2.7 and 1.5-20 μM, for human COX-1 and COX-2, respectively). It is also an active metabolite of diclofenac methyl ester and diclofenac amide . Diclofenac inhibits release of arachidonic acid (Item Nos. 90010 | 90010.1 | 10006607) induced by A23187 in isolated rat peritoneal neutrophils and macrophages (IC50s = 60 and 10 μM, respectively). Transdermal administration of diclofenac inhibits carrageenan-induced paw edema in rats. Formulations containing diclofenac have been used in the treatment of pain associated with osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis.

역사Diclofenac sodium is a classic nonsteroidal anti-inflammatory drug (NSAID), known for its potent antipyretic, analgesic, and anti-inflammatory effects, and is marketed under brand names such as Voltaren. Its discovery and widespread use have had a profound impact on the treatment of pain and inflammation.Discovery and Patent (1965): Diclofenac sodium was synthesized by a team of researchers Rudolf Pfister and Alfred Sallmann at the Swiss pharmaceutical company Ciba-Geigy AG (now part of Novartis) while searching for a highly active and well-tolerated NSAID. The compound was patented in 1965.First Market Launch (1973): After extensive preclinical and clinical trials, diclofenac sodium was first marketed globally in 1973 under the brand name Voltaren. Its design philosophy is based on clear principles and aims to be an effective cyclooxygenase (COX) inhibitor.

용도Diclofenac sodium is a nonsteroidal anti-inflammatory compound and cyclooxygenase (COX) inhibitor. Oxidation of diclofenac sodium produces the metabolite 4'-hydroxy diclofenac) which demonstrates specific inhibition of Cox-2. Inhibition of Cox by diclofenac and 4'-hydroxy diclofenac suppresses prostaglandin E2 synthesis, producing anti-inflammatory and analgesic effects. Diclofenac is also shown to stabilize the native tetrameric conformation of transthyretin (TTR) fibrils, preventing the formation of insoluble amyloidogenic TTR deposits. Diclofenac Sodium is a substrate of CYP2C9. It is also used as an inhibitor of Cox-1 and Cox-2.

일반 설명Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.Diclofenac is a derivative of benzeneacetic acid. It is categorized under the class of non-steroidal anti-inflammatory drugs (NSAIDs). It shows inflammatory, analgesic and antipyretic activities.

상·하류 제품 정보

상류 원료

에틸알코올클로로아세틸 클로라이드2,6-디클로로페놀2-클로로벤조익산아닐린2,5-디클로로아닐린o-클로로톨루엔2,6-디클로로아닐린수산화나트륨염화알루미늄

하류 제품

1-(2,6-Dichlorophenyl)-2-hydroindole디클로페낙메틸에스테르Oxindole

추가 설명

정의ChEBI: Diclofenac sodium is the sodium salt of diclofenac. It contains a diclofenac(1-).

관련 반응

24건
반응 기록 만들기
HRID 356790 반응식
HRID 356790반응물로
HRID 371113 반응식
HRID 371113반응물로
HRID 464711 반응식
HRID 464711반응물로
HRID 990889 반응식
HRID 990889반응물로
HRID 1360001 반응식
HRID 1360001반응물로
HRID 1420867 반응식
HRID 1420867반응물로
HRID 1517222 반응식
HRID 1517222반응물로
HRID 1660668 반응식
HRID 1660668반응물로
이전1 / 3 페이지

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트